555 related articles for article (PubMed ID: 19012362)
21. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
[TBL] [Abstract][Full Text] [Related]
22. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.
Uramoto KM; Michet CJ; Thumboo J; Sunku J; O'Fallon WM; Gabriel SE
Arthritis Rheum; 1999 Jan; 42(1):46-50. PubMed ID: 9920013
[TBL] [Abstract][Full Text] [Related]
23. Fibrinogen in systemic lupus erythematosus: more than an acute phase reactant?
Ames PR; Alves J; Pap AF; Ramos P; Khamashta MA; Hughes GR
J Rheumatol; 2000 May; 27(5):1190-5. PubMed ID: 10813286
[TBL] [Abstract][Full Text] [Related]
24. Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosus.
Becker-Merok A; Nossent J
Lupus; 2009 May; 18(6):508-15. PubMed ID: 19395452
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
Grönhagen CM; Fored CM; Granath F; Nyberg F
Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
[TBL] [Abstract][Full Text] [Related]
26. Reproductive factors and risk of systemic lupus erythematosus: nationwide cohort study in Denmark.
Ulff-Møller CJ; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
J Rheumatol; 2009 Sep; 36(9):1903-9. PubMed ID: 19567628
[TBL] [Abstract][Full Text] [Related]
27. Risk factors of mortality for salmonella infection in systemic lupus erythematosus.
Tsao CH; Chen CY; Ou LS; Huang JL
J Rheumatol; 2002 Jun; 29(6):1214-8. PubMed ID: 12064838
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of thyroid dysfunction in systemic lupus erythematosus.
Appenzeller S; Pallone AT; Natalin RA; Costallat LT
J Clin Rheumatol; 2009 Apr; 15(3):117-9. PubMed ID: 19300286
[TBL] [Abstract][Full Text] [Related]
29. Incidence and risk factors of infection in a single cohort of 110 adults with systemic lupus erythematosus.
Jeong SJ; Choi H; Lee HS; Han SH; Chin BS; Baek JH; Kim CO; Choi JY; Song YG; Kim JM
Scand J Infect Dis; 2009; 41(4):268-74. PubMed ID: 19172435
[TBL] [Abstract][Full Text] [Related]
30. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.
Rabbani MA; Habib HB; Islam M; Ahmad B; Majid S; Saeed W; Shah SM; Ahmad A
Lupus; 2009 Aug; 18(9):848-55. PubMed ID: 19578112
[TBL] [Abstract][Full Text] [Related]
31. Infections increase risk of arterial and venous thromboses in Danish patients with systemic lupus erythematosus: 5102 patient-years of followup.
Baronaite Hansen R; Jacobsen S
J Rheumatol; 2014 Sep; 41(9):1817-22. PubMed ID: 25128505
[TBL] [Abstract][Full Text] [Related]
32. Occurrence of systemic lupus erythematosus in a Danish community: an 8-year prospective study.
Laustrup H; Voss A; Green A; Junker P
Scand J Rheumatol; 2009; 38(2):128-32. PubMed ID: 19117248
[TBL] [Abstract][Full Text] [Related]
33. Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus.
Fragoso-Loyo HE; Sánchez-Guerrero J
J Rheumatol; 2007 Jan; 34(1):76-80. PubMed ID: 17143970
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with active systemic lupus erythematosus after endstage renal disease.
Szeto CC; Li PK; Wong TY; Leung CB; Lui SF
J Rheumatol; 1998 Aug; 25(8):1520-5. PubMed ID: 9712094
[TBL] [Abstract][Full Text] [Related]
35. [Allergic manifestations of systemic lupus erythematosus].
Diumenjo MS; Lisanti M; Vallés R; Rivero I
Allergol Immunopathol (Madr); 1985; 13(4):323-6. PubMed ID: 4083230
[TBL] [Abstract][Full Text] [Related]
36. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon.
Rodriguez VE; Gonzalez-Pares EN; Rivera C
P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096
[TBL] [Abstract][Full Text] [Related]
37. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
38. Natural history of hypercholesterolemia in systemic lupus erythematosus.
Bruce IN; Urowitz MB; Gladman DD; Hallett DC
J Rheumatol; 1999 Oct; 26(10):2137-43. PubMed ID: 10529129
[TBL] [Abstract][Full Text] [Related]
39. Adult celiac disease followed by onset of systemic lupus erythematosus.
Freeman HJ
J Clin Gastroenterol; 2008 Mar; 42(3):252-5. PubMed ID: 18223501
[TBL] [Abstract][Full Text] [Related]
40. [Risk factors for the development of thrombotic complication in patients with lupus erythematosus and lupus nephropatic].
Zaldívar-Alcántara H; Herrera-Jiménez LE; Dehesa-López E; Correa-Rotter R
Rev Invest Clin; 2013; 65(3):199-208. PubMed ID: 23877806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
